Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grüner

Showing results (641-650 of 673) with videos related to

Pageof 68
Sort By:
Plos One|July 27, 2007
Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infectionMichaela Lucas, Axel Ulsenheimer, Katja Pfafferot, et al.
Eclinicalmedicine|December 27, 2024
Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platformJennifer L Nguyen, Marianna Mitratza, Hannah R Volkman, et al.
American Journal of Human Genetics|December 26, 2017
Missense Variants in RHOBTB2 Cause a Developmental and Epileptic Encephalopathy in Humans, and Altered Levels Cause Neurological Defects in DrosophilaJonas Straub, Enrico D H Konrad, Johanna Grüner, et al.
BMJ Open|March 6, 2023
Quality contract 'prevention of postoperative delirium in the care of elderly patients' study protocol: a non-randomised, pre-post, monocentric, prospective trialFatima Yürek, Julian-Dominic Zimmermann, Elisa Weidner, et al.
Ebiomedicine|February 28, 2025
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trialSimone Hoffmann, Eva Schrezenmeier, Maxime Desmarets, et al.
Cancer Cell|September 15, 2012
EGF receptor is required for KRAS-induced pancreatic tumorigenesisChristine M Ardito, Barbara M Grüner, Kenneth K Takeuchi, et al.
Infectious Diseases and Therapy|July 7, 2026
Viral Pathogen-Specific Severe Acute Respiratory Infections in Hospitalised Adults in Europe: Epidemiological Findings from the id.DRIVE Study 2024-2025Katherine Newell, Nikki Vroom, Cátia Marques, et al.
Nature Communications|April 4, 2025
Preclinical concept studies showing advantage of an inhaled anti-CTGF/CCN2 protein for pulmonary fibrosis treatmentVanessa Neiens, Eva-Maria Hansbauer, Thomas J Jaquin, et al.
Science (New York, N.Y.)|March 17, 2023
Decrypting drug actions and protein modifications by dose- and time-resolved proteomicsJana Zecha, Florian P Bayer, Svenja Wiechmann, et al.
Infection|October 1, 2020
First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)"Carolin E M Jakob, Stefan Borgmann, Fazilet Duygu, et al.
Pageof 68

Showing results (641-650 of 673) with videos related to

Sort By:
Pageof 68
Plos One|July 27, 2007
Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infectionMichaela Lucas, Axel Ulsenheimer, Katja Pfafferot, et al.
Eclinicalmedicine|December 27, 2024
Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platformJennifer L Nguyen, Marianna Mitratza, Hannah R Volkman, et al.
American Journal of Human Genetics|December 26, 2017
Missense Variants in RHOBTB2 Cause a Developmental and Epileptic Encephalopathy in Humans, and Altered Levels Cause Neurological Defects in DrosophilaJonas Straub, Enrico D H Konrad, Johanna Grüner, et al.
BMJ Open|March 6, 2023
Quality contract 'prevention of postoperative delirium in the care of elderly patients' study protocol: a non-randomised, pre-post, monocentric, prospective trialFatima Yürek, Julian-Dominic Zimmermann, Elisa Weidner, et al.
Ebiomedicine|February 28, 2025
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trialSimone Hoffmann, Eva Schrezenmeier, Maxime Desmarets, et al.
Cancer Cell|September 15, 2012
EGF receptor is required for KRAS-induced pancreatic tumorigenesisChristine M Ardito, Barbara M Grüner, Kenneth K Takeuchi, et al.
Infectious Diseases and Therapy|July 7, 2026
Viral Pathogen-Specific Severe Acute Respiratory Infections in Hospitalised Adults in Europe: Epidemiological Findings from the id.DRIVE Study 2024-2025Katherine Newell, Nikki Vroom, Cátia Marques, et al.
Nature Communications|April 4, 2025
Preclinical concept studies showing advantage of an inhaled anti-CTGF/CCN2 protein for pulmonary fibrosis treatmentVanessa Neiens, Eva-Maria Hansbauer, Thomas J Jaquin, et al.
Science (New York, N.Y.)|March 17, 2023
Decrypting drug actions and protein modifications by dose- and time-resolved proteomicsJana Zecha, Florian P Bayer, Svenja Wiechmann, et al.
Infection|October 1, 2020
First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)"Carolin E M Jakob, Stefan Borgmann, Fazilet Duygu, et al.
Pageof 68